Armata Pharmaceuticals, Inc.
ARMP
$1.42
$0.06815.04%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.60M | -5.48M | 8.99M | -25.02M | -19.85M |
| Total Depreciation and Amortization | 380.00K | 313.00K | 315.00K | 317.00K | 293.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.10M | -2.76M | -18.82M | 15.81M | 10.89M |
| Change in Net Operating Assets | 1.19M | -935.00K | -661.00K | -1.69M | 557.00K |
| Cash from Operations | -7.93M | -8.86M | -10.18M | -10.58M | -8.11M |
| Capital Expenditure | 77.00K | -340.00K | -1.37M | -250.00K | -2.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 10.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 77.00K | -340.00K | -1.37M | -250.00K | -2.39M |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 34.89M | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 88.00K | 42.00K | 0.00 |
| Repurchase of Common Stock | 0.00 | -61.00K | -- | -- | -43.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | -61.00K | 88.00K | 34.93M | -43.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.85M | -9.26M | -11.46M | 24.10M | -10.54M |